Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052072 · ClinicalTrials.gov registry record · NA
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)
A NA study of Heart Failure and Group 2 Pulmonary Hypertension, sponsored by Gradient Denervation Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 8
- Study locations
NCT06052072: Recruiting NA study of Heart Failure and Group 2 Pulmonary Hypertension, sponsored by Gradient Denervation Technologies.
NCT06052072 is a NA study of Heart Failure and Group 2 Pulmonary Hypertension that is actively recruiting participants, run by Gradient Denervation Technologies. The registered enrollment target is 50 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06052072, a NA study of Heart Failure and Group 2 Pulmonary Hypertension, is actively recruiting participants, sponsored by Gradient Denervation Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 8
- Study locations
Study Summary
This early feasibility study is intended to characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension
Conditions Studied
Interventions
- DEVICE Gradient Denervation System
Study Locations (8)
Texas
- Baylor College of Medicine - Houston
- Houston Methodist - Houston
Wisconsin
- University of Wisconsin - Madison
- Aurora Health - Milwaukee
Illinois
- Northwestern University - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
North Carolina
- Duke University - Durham
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-02-20 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
What NCT06052072 shows while recruiting
NCT06052072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Gradient Denervation System is the first listed.
NCT06052072 lists 8 locations in 6 states (Texas, Wisconsin, Illinois).
Frequently Asked Questions
What is clinical trial NCT06052072 about?
NCT06052072 is a clinical study titled "Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)". This early feasibility study is intended to characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension
What is the current status of trial NCT06052072?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-02-20. Estimated completion is 2028-07-01.
What conditions does trial NCT06052072 study?
This clinical trial studies the following conditions: Heart Failure, Group 2 Pulmonary Hypertension.
What interventions are being tested in trial NCT06052072?
The interventions under investigation include: Gradient Denervation System (DEVICE).
Who is sponsoring clinical trial NCT06052072?
This trial is sponsored by Gradient Denervation Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052072 being conducted?
This trial has 8 study locations across Illinois, Massachusetts, North Carolina, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06052072's enrollment target sits among peer trials
50 281st of 397 higher than 106 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI